Eni Brake Fluid DOT 4 BX

Hazard statements (CLP)

H361

Code

Statements

H361

Suspected of damaging fertility or the unborn child

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP)]

2.1 Classification of the substance or mixture

Classification

Adverse physicochemical, human health and environmental effects

For specific information about the toxicological/ecotoxicological properties and classification of this product, see Sect. 11 and/or Sect. 12.

2.2 Label elements

Labelling

Hazard pictograms

GHS08

Signal word

Warning

Contains

Tris[2-[2-(2-methoxyethoxy)ethoxy]ethyl]orthoborate

Hazard statements

H361 - Suspected of damaging fertility or the unborn child.

Precautionary statements

P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P308+P313 - IF exposed or concerned: Get medical advice/attention. P405 - Store locked up. P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation. Nordic countries regulation Denmark MAL code : 00-1 (Executive Order No. 301 from 1993) 2.3. Other hazards (not relevant for classification) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII

Further information

The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %. Component Tris[2-[2-(2-methoxyethoxy)ethoxy]ethyl]orthoborate This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII (30989-05-0) This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Reaction mass of 2-(2-(2- This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII butoxyethoxy)ethoxy)ethanol and 3,6,9,12- This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII tetraoxahexadecan-1-ol 2,2' -oxybisethanol; diethylene glycol (111-46-6) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component Tris[2-[2-(2- The substance is not included in the list established in accordance with Article 59(1) of methoxyethoxy)ethoxy]ethyl]orthoborate(30989-05-0) REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Reaction mass of 2-(2-(2- The substance is not included in the list established in accordance with Article 59(1) of butoxyethoxy)ethoxy)ethanol and 3,6,9,12- REACH for having endocrine disrupting properties, or is not identified as having endocrine tetraoxahexadecan-1-ol disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 2,2' -oxybisethanol; diethylene glycol(111-46-6) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605